What is the NEU?

The Neuroepidemiology Unit (NEU) of the Melbourne School of Population and Global Health at the University of Melbourne was formed in 2015, building on the international profile in MS prevention of its head, Professor George Jelinek.

The Neuroepidemiology Unit (NEU) of the Melbourne School of Population and Global Health at the University of Melbourne was formed in 2015, building on the international profile in MS prevention of its founder, Professor George Jelinek. Associate Professor Tracey Weiland is now the Principal Research Fellow and Head of the Neuroepidemiology Unit, School of Population and Global Health

The NEU has developed novel methods of accessing unique preventive medicine data from large communities of people with MS. It leads research into the potential for lifestyle-based preventive medicine approaches for MS. The NEU’s research has led to numerous papers published in leading medical journals investigating the building blocks and outcomes of the 7-Step OMS Recovery Program.

The NEU conducts several studies related to primary and secondary prevention of MS, including the longitudinal HOLISM Study and the STOP MS study.

The NEU is planning to design and conduct randomized controlled trials examining novel methods of delivery of lifestyle-based secondary and tertiary preventive measures, including web-based educational applications; qualitative studies of preventive medicine aspects of the health of people with MS and their partners; and other studies developed in discussion with the Unit’s Scientific Advisory Group.


Pictured: Associate Professor Tracey Weiland (left) and Professor George Jelinek (right).